🔎 Trials Near Me

Dachaigh › Purpura Thrombocytopenic Idiopathic › New York › The Bronx

Sgrùdaidhean clionaigeach Purpura Thrombocytopenic Idiopathic ann an The Bronx, NY

Tha 5 sgrùdaidhean airson Purpura Thrombocytopenic Idiopathic a’ lorg phàirtichean aig làraichean ann agus timcheall air The Bronx (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

A’ fastadhÌre 2
  • Montefiore Medical Center, The Bronx
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07421167

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

A’ fastadhÌre 3
  • Montefiore Medical Center, The Bronx
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

A’ fastadhÌre 2
  • Montefiore Medical Center, The Bronx
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07104565

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

A’ fastadhÌre 3
  • Montefiore Medical Center, The Bronx
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

A’ fastadhÌre 3
  • Montefiore Medical Center-Investigational Site Number: 8400012, The Bronx
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07007962

Sgrùdaidhean Purpura Thrombocytopenic Idiopathic ann am bailtean eile

Sgrùdaidhean eile ann an The Bronx

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.